Bafna Pharmaceuticals
BAFNAPHNSE

Bafna Pharmaceuticals

₹134.002.16 (1.64%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
130.01
Today’s high
136.00
52 week low
71.57
52 week high
202.06
Open price
136.00
Previous close
131.84
Live volume
867
Lower circuit
125.25
Upper circuit
138.43

Fundamentals

Market Cap
₹320Cr
ROE
11.59%
P/E Ratio(TTM)
33.16
EPS(TTM)
4.08
P/B Ratio
3.51
Dividend Yield
0.00%
Industry P/E
41.54
Book Value
38.56
Debt to Equity
0.36
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹39.51
+7.80%
Profit (Cr)
₹1.84
-41.03%
012.52537.550
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+18%
3Y CAGR+20%
Profit growthValue
1Y (TTM)+94%
3Y CAGR-7.0%

About

Bafna Pharmaceuticals Limited manufactures pharmaceutical formulations, including betalactum and non-betalactum products, for domestic and export markets.;
CEO/MD
Bafna Mahaveer Chand
Founded in
1995
NSE symbol
BAFNAPH

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
75.00%
Retail And Others
15.66%
Foreign Institutions
9.34%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹752.05
+23.65 (3.25%)
L
    H
    4,181.7131.584.1
    ₹363.58
    -12.06 (3.21%)
    L
      H
      4,095.4685.6215.49
      ₹403.70
      -6.40 (1.56%)
      L
        H
        3,837.8642.825.26
        Aarti DrugsAARTIDRUGS
        ₹376.30
        +2.95 (0.79%)
        L
          H
          3,411.2216.852.32
          2026
          11
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks